Rigor Is Needed When Making Comparative Analyses of Biologics in Severe Asthma
- PMID: 29360390
- DOI: 10.1164/rccm.201712-2455LE
Rigor Is Needed When Making Comparative Analyses of Biologics in Severe Asthma
Comment on
-
Weight-adjusted Intravenous Reslizumab in Severe Asthma with Inadequate Response to Fixed-Dose Subcutaneous Mepolizumab.Am J Respir Crit Care Med. 2018 Jan 1;197(1):38-46. doi: 10.1164/rccm.201707-1323OC. Am J Respir Crit Care Med. 2018. PMID: 28915080 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical